Of the five known CD74 fusions, CD74-ROS1 is the most prevalent among ROS1 fusion proteins in NSCLC [74,126,127,128], and based on the data collected in this review, also appears to be the most prevalent partner among CD74-related fusions. This evidence concerns the gene ROS1 and non-small cell lung carcinoma.